Skip to content
Menu

Iambic Therapeutics, Inc. IAM

Full chart Compare
Set alert

Price alert · IAM

All alert types
13.11 USD -1.15 (-8.06%)

Regular-session close

13.62 +0.51 +3.89%

After hours · Nov 20, 4:00 PM ET

12.77 Day range 14.00
9.60 52-week range 25.00
YTD
-30.67%
1 year
-30.67%

Revenue & Expenses

Revenue Profit Costs
Other Income$5.12MGross Profit$9.43MNet Loss$77.30MExpenses$91.84MSelling, General & Admin$14.25MResearch & Development$77.53MInterest Expense$17.00KIncome Tax$45.00KRevenue$9.43M

Latest period ending Dec 31, 2025 · select a line to chart its full history

IAM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
9.43M1.19M
9.43M1.19M
-82.35M-53.88M
-77.30M-47.88M
-3.57-2.23
IAM annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
180.54M141.58M
195.02M155.75M
40.25M25.34M
5.46M6.21M
-186.56M-112.25M
IAM annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-58.82M-33.56M
-1.28M-707.00K
99.06M64.99M
-1.28M-707.00K
38.96M30.73M